Health Tech — sector dashboard · fobi

BriefingFree Daily Briefing

Funding & analysis

Company

00

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

Total Raised

Round sizes
Mega-rounds ($200M+) dominate 2025–2026: Oura Series E ($900M), Whoop Series G ($575M), Verily growth ($300M), Abridge Series E ($300M). Median early-stage rounds remain $20–70M. Seed and Series A funding compressed, while growth/late-stage capital surged past 12 months.
Stage mix
Capital heavily concentrated in Series D–growth stage. Oura, Whoop, Abridge, Aidoc, Hippocratic AI, Innovaccer raised $2.9B across late-stage rounds in past 18 months. Seed funding nearly absent. Series A–B activity minimal. Reflects mature cohort maturing, not sector breadth.
Lead investors
General Catalyst, Andreessen Horowitz, Fidelity Management lead repeat deals. Newer mega-ticket players: Avenir Growth, Collaborative Fund, Goldman Sachs Alternatives, Series X Capital entered 2025–2026. Traditional tier-1 VCs (Kleiner Perkins, Sequoia, Tiger Global) quiet on recent rounds; corporate/growth PE dominate.